TABLE OF CONTENTS
Volume 29, Issue 4 (April 2004)
Perspective
Importance of Studying the Contributions of Early Adverse Experience to Neurobiological Findings in Depression FREE
Christine Heim, Paul M Plotsky and Charles B Nemeroff
Neuropsychopharmacology 29: 641-648; advance online publication, March 3, 2004; doi:10.1038/sj.npp.1300397
Original Articles
The 
-Opioid Receptor Agonist (+)BW373U86 Regulates BDNF mRNA Expression in Rats FREE
Mary M Torregrossa, Ceylan Isgor, John E Folk, Kenner C Rice, Stanley J Watson and James H Woods
Neuropsychopharmacology 29: 649-659; advance online publication, November 26, 2003; doi:10.1038/sj.npp.1300345
Differential Roles of 5-HT Receptor Subtypes in Cue and Cocaine Reinstatement of Cocaine-Seeking Behavior in Rats FREE
Jeffrey J Burmeister, Erin M Lungren, Kenneth F Kirschner and Janet L Neisewander
Neuropsychopharmacology 29: 660-668; advance online publication, November 12, 2003; doi:10.1038/sj.npp.1300346
Effects of Cocaine Self-Administration on Food-Reinforced Responding Using a Discrete Trial Procedure in Rats FREE
W J Lynch and D C S Roberts
Neuropsychopharmacology 29: 669-675; advance online publication, December 17, 2003; doi:10.1038/sj.npp.1300363
Phasic Alterations in Dopamine and Serotonin Release in Striatum and Prefrontal Cortex in Response to Cocaine Predictive Cues in Behaving Rhesus Macaques FREE
Charles W Bradberry and Susan R Rubino
Neuropsychopharmacology 29: 676-685; advance online publication, January 28, 2004; doi:10.1038/sj.npp.1300386
Pharmacological Blockade of 
2-Adrenoceptors Induces Reinstatement of Cocaine-Seeking Behavior in Squirrel Monkeys FREE
Buyean Lee, Stefan Tiefenbacher, Donna M Platt and Roger D Spealman
Neuropsychopharmacology 29: 686-693; advance online publication, February 11, 2004; doi:10.1038/sj.npp.1300391
Chronic Fluoxetine Treatment Partly Attenuates the Long-Term Anxiety and Depressive Symptoms Induced by MDMA ('Ecstasy') in Rats FREE
Murray R Thompson, Kong M Li, Kelly J Clemens, Clint G Gurtman, Glenn E Hunt, Jennifer L Cornish and Iain S McGregor
Neuropsychopharmacology 29: 694-704; advance online publication, November 12, 2003; doi:10.1038/sj.npp.1300347
Histamine H3 Receptor Antagonists Potentiate Methamphetamine Self-Administration and Methamphetamine-Induced Accumbal Dopamine Release FREE
Patrik Munzar, Gianluigi Tanda, Zuzana Justinova and Steven R Goldberg
Neuropsychopharmacology 29: 705-717; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300380
Sexual Behavior and Sex-Associated Environmental Cues Activate the Mesolimbic System in Male Rats FREE
Margaret E Balfour, Lei Yu and Lique M Coolen
Neuropsychopharmacology 29: 718-730; advance online publication, December 23, 2003; doi:10.1038/sj.npp.1300350
Reversal of Sensorimotor Gating Deficits in Brattleboro Rats by Acute Administration of Clozapine and a Neurotensin Agonist, but not Haloperidol: a Potential Predictive Model for Novel Antipsychotic Effects FREE
David Feifel, Gilia Melendez and Paul D Shilling
Neuropsychopharmacology 29: 731-738; advance online publication, February 4, 2004; doi:10.1038/sj.npp.1300378
Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse N1 Auditory Evoked Potential FREE
Christina R Maxwell, Yuling Liang, Bryanne D Weightman, Stephen J Kanes, Ted Abel, Raquel E Gur, Bruce I Turetsky, Warren B Bilker, Robert H Lenox and Steven J Siegel
Neuropsychopharmacology 29: 739-746; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300376
Simulated Apoptosis/Neurogenesis Regulates Learning and Memory Capabilities of Adaptive Neural Networks FREE
R Andrew Chambers, Marc N Potenza, Ralph E Hoffman and Willard Miranker
Neuropsychopharmacology 29: 747-758; advance online publication, December 31, 2003; doi:10.1038/sj.npp.1300358
Chronic Lithium Treatment Attenuates Intracellular Calcium Mobilization FREE
Michael J Wasserman, Timothy W Corson, David Sibony, Robert G Cooke, Sagar V Parikh, Peter S Pennefather, Peter P Li and Jerry J Warsh
Neuropsychopharmacology 29: 759-769; advance online publication, February 18, 2004; doi:10.1038/sj.npp.1300400
Reduced Immobility in the Forced Swim Test in Mice with a Targeted Deletion of the Leukemia Inhibitory Factor (LIF) Gene FREE
Robert N Pechnick, Vera M Chesnokova, Anastasia Kariagina, Shannon Price, Catherine J Bresee and Russell E Poland
Neuropsychopharmacology 29: 770-776; advance online publication, February 18, 2004; doi:10.1038/sj.npp.1300402
Cerebrospinal Fluid Corticotropin-Releasing Factor and Perceived Early-Life Stress in Depressed Patients and Healthy Control Subjects FREE
Linda L Carpenter, Audrey R Tyrka, Christopher J McDougle, Robert T Malison, Michael J Owens, Charles B Nemeroff and Lawrence H Price
Neuropsychopharmacology 29: 777-784; advance online publication, December 31, 2003; doi:10.1038/sj.npp.1300375
Regulation of the Human Corticotropin-Releasing-Hormone Gene Promoter Activity by Antidepressant Drugs in Neuro-2A and AtT-20 Cells FREE
Bogus
awa Budziszewska, Lucylla Jaworska-Feil, Magdalena Tetich, Agnieszka Basta-Kaim, Marta Kubera, Monika Le
kiewicz and Wadysaw Laso
Neuropsychopharmacology 29: 785-794; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300379
BDNF Serum Concentrations in Healthy Volunteers are Associated with Depression-Related Personality Traits FREE
Undine E Lang, Rainer Hellweg and Jürgen Gallinat
Neuropsychopharmacology 29: 795-798; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300382
Identification of Lithium-Regulated Genes in Cultured Lymphoblasts of Lithium Responsive Subjects with Bipolar Disorder FREE
Xiujun Sun, L Trevor Young, Jun-Feng Wang, Paul Grof, Gustavo Turecki, Guy A Rouleau and Martin Alda
Neuropsychopharmacology 29: 799-804; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300383
Drug-Induced Decrease of Protein Kinase A Activity Reveals Alteration in BDNF Expression of Bipolar Affective Disorder FREE
Félicien Karege, Michèle Schwald and Rachid El Kouaissi
Neuropsychopharmacology 29: 805-812; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300384
Seizure Expression During Electroconvulsive Therapy: Relationships with Clinical Outcome and Cognitive Side Effects FREE
Tarique D Perera, Bruce Luber, Mitchell S Nobler, Joan Prudic, Christopher Anderson and Harold A Sackeim
Neuropsychopharmacology 29: 813-825; advance online publication, January 21, 2004; doi:10.1038/sj.npp.1300377
Amygdala Volume Reductions in Pediatric Patients with Obsessive–Compulsive Disorder Treated with Paroxetine: Preliminary Findings FREE
Philip R Szeszko, Shauna MacMillan, Marjorie McMeniman, Elisa Lorch, Rachel Madden, Jennifer Ivey, S Preeya Banerjee, Gregory J Moore and David R Rosenberg
Neuropsychopharmacology 29: 826-832; advance online publication, February 18, 2004; doi:10.1038/sj.npp.1300399
